Immuneering (IMRX) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Immuneering (IMRX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 40K (-55.56%) | 90K (-50.00%) | 180K (-5.26%) | 190K (-60.42%) | 480K (-27.27%) | 660K (-12.00%) | 750K (-34.78%) | 1.15M (+69.12%) | 680K (+41.67%) | 480K | - |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20K (-60.00%) | 50K (-44.44%) | 90K (-57.14%) | 210K (-4.55%) | 220K (-31.25%) | 320K (-21.95%) | 410K (-43.84%) | 730K (+128.13%) | 320K (+33.33%) | 240K | - |
Costof Goods And Services Sold | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20K (-60.00%) | 50K (-44.44%) | 90K (-57.14%) | 210K (-4.55%) | 220K (-31.25%) | 320K (-21.95%) | 410K (-43.84%) | 730K (+128.13%) | 320K (+33.33%) | 240K | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20K (-60.00%) | 50K (-44.44%) | 90K | -20.00K | 260K (-23.53%) | 340K (0.00%) | 340K (-19.05%) | 420K (+13.51%) | 370K (+54.17%) | 240K | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 11M (+15.14%) | 9.25M (-14.90%) | 11M (+4.02%) | 10M (-8.89%) | 11M (-22.81%) | 15M (+32.09%) | 11M (+5.63%) | 11M (-4.91%) | 11M (-5.96%) | 12M (+18.51%) | 10M (+6.35%) | 9.45M (-7.44%) | 10M (+3.55%) | 9.86M (+5.34%) | 9.36M (+17.29%) | 7.98M (-11.92%) | 9.06M (+13.96%) | 7.95M (+28.02%) | 6.21M (-11.16%) | 6.99M (+29.68%) | 5.39M (-30.09%) | 7.71M (+89.43%) | 4.07M (+26.40%) | 3.22M | - |
Selling General And Administrative | 4.68M (+4.23%) | 4.49M (-0.44%) | 4.51M (+4.88%) | 4.30M (+7.23%) | 4.01M (+8.67%) | 3.69M (-7.98%) | 4.01M (-5.65%) | 4.25M (+3.16%) | 4.12M (-5.94%) | 4.38M (+13.18%) | 3.87M (-4.21%) | 4.04M (-9.42%) | 4.46M (+8.52%) | 4.11M (+7.03%) | 3.84M (+3.78%) | 3.70M (-6.33%) | 3.95M (+25.40%) | 3.15M (+21.15%) | 2.60M (+94.03%) | 1.34M (+13.56%) | 1.18M (-33.71%) | 1.78M (+154.29%) | 700K (+11.11%) | 630K | - |
Operating Expenses | 15M (+11.56%) | 14M (-10.60%) | 15M (+4.20%) | 15M (-4.65%) | 15M (-16.59%) | 19M (+21.55%) | 15M (+2.41%) | 15M (-2.74%) | 15M (-5.95%) | 16M (+17.01%) | 14M (+3.19%) | 14M (-8.04%) | 15M (+4.93%) | 14M (+5.90%) | 13M (+13.00%) | 12M (-10.22%) | 13M (+17.30%) | 11M (+25.99%) | 8.81M (+5.76%) | 8.33M (+26.60%) | 6.58M (-30.74%) | 9.50M (+99.16%) | 4.77M (+23.90%) | 3.85M | - |
Depreciation And Amortization | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (-11.11%) | 90K (0.00%) | 90K (0.00%) | 90K (0.00%) | 90K (0.00%) | 90K (0.00%) | 90K (+12.50%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (+14.29%) | 70K (+40.00%) | 50K (0.00%) | 50K (+400.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -15.34M (+11.56%) | -13.75M (-10.60%) | -15.38M (+4.20%) | -14.76M (-4.65%) | -15.48M (-16.59%) | -18.56M (+21.55%) | -15.27M (+2.41%) | -14.91M (-2.74%) | -15.33M (-5.95%) | -16.30M (+17.01%) | -13.93M (+3.19%) | -13.50M (-8.04%) | -14.68M (+4.93%) | -13.99M (+6.07%) | -13.19M (+13.22%) | -11.65M (-9.90%) | -12.93M (+16.28%) | -11.12M (+30.21%) | -8.54M (+6.88%) | -7.99M (+28.04%) | -6.24M (-31.28%) | -9.08M (+106.36%) | -4.40M (+21.88%) | -3.61M | - |
Ebit | -15.34M (+11.56%) | -13.75M (-10.60%) | -15.38M (+4.20%) | -14.76M (-4.65%) | -15.48M (-16.59%) | -18.56M (+21.55%) | -15.27M (+2.41%) | -14.91M (-2.74%) | -15.33M (-5.95%) | -16.30M (+17.01%) | -13.93M (+3.19%) | -13.50M (-8.04%) | -14.68M (+4.93%) | -13.99M (+6.07%) | -13.19M (+13.22%) | -11.65M (-9.90%) | -12.93M (+16.28%) | -11.12M (+30.21%) | -8.54M (+6.88%) | -7.99M (+28.04%) | -6.24M (+6.30%) | -5.87M (+33.41%) | -4.40M (+21.88%) | -3.61M (+12.81%) | -3.20M |
EBITDA | -15.25M (+11.48%) | -13.68M (-10.59%) | -15.30M (+4.29%) | -14.67M (-4.74%) | -15.40M (-16.62%) | -18.47M (+21.67%) | -15.18M (+2.43%) | -14.82M (-2.76%) | -15.24M (-5.98%) | -16.21M (+17.04%) | -13.85M (+3.13%) | -13.43M (-8.01%) | -14.60M (+4.96%) | -13.91M (+6.02%) | -13.12M (+13.20%) | -11.59M (-10.02%) | -12.88M (+16.04%) | -11.10M (+30.13%) | -8.53M (+6.89%) | -7.98M (+28.09%) | -6.23M (+6.31%) | -5.86M (+33.49%) | -4.39M (+21.94%) | -3.60M (+12.50%) | -3.20M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 1.36M (-26.88%) | 1.86M (+342.86%) | 420K (+31.25%) | 320K (-27.27%) | 440K (+4.76%) | 420K (-23.64%) | 550K (-33.73%) | 830K (+3.75%) | 800K (+6.67%) | 750K (-12.79%) | 860K (-26.50%) | 1.17M (+40.96%) | 830K (+59.62%) | 520K (+136.36%) | 220K (+57.14%) | 140K (+7.69%) | 130K (-7.14%) | 140K (+600.00%) | 20K | - | 10K (-75.00%) | 40K | - | - | - |
Net Interest Income | 1.36M (-26.88%) | 1.86M (+342.86%) | 420K (+31.25%) | 320K (-27.27%) | 440K (+4.76%) | 420K (-23.64%) | 550K (-33.73%) | 830K (+3.75%) | 800K (+6.67%) | 750K (-12.79%) | 860K (-26.50%) | 1.17M (+40.96%) | 830K (+59.62%) | 520K (+136.36%) | 220K (+57.14%) | 140K (+7.69%) | 130K (-7.14%) | 140K (+600.00%) | 20K | - | 10K (-75.00%) | 40K | - | - | - |
Other Non Operating Income | 510K (+64.52%) | 310K | - | - | - | 440K (+238.46%) | 130K (+1200.00%) | 10K (-95.24%) | 210K (-84.21%) | 1.33M (+177.08%) | 480K (+220.00%) | 150K (-37.50%) | 240K (+9.09%) | 220K (+83.33%) | 120K | -20.00K (-80.00%) | -100.00K (-23.08%) | -130.00K (+1200.00%) | -10.00K | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | -50.51M | - | - | - | -33.84M | - | - | - | -17.04M | - | - | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -310.00K | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -13.46M (+16.23%) | -11.58M (-22.59%) | -14.96M (+3.67%) | -14.43M (-4.12%) | -15.05M (-16.62%) | -18.05M (+23.63%) | -14.60M (+3.69%) | -14.08M (-1.61%) | -14.31M (-5.11%) | -15.08M (+19.68%) | -12.60M (+3.36%) | -12.19M (-10.37%) | -13.60M (+2.64%) | -13.25M (+3.19%) | -12.84M (+11.36%) | -11.53M (-10.62%) | -12.90M (+19.67%) | -10.78M (+26.38%) | -8.53M (+6.76%) | -7.99M (+28.25%) | -6.23M (+6.68%) | -5.84M (+32.73%) | -4.40M (+22.22%) | -3.60M (+12.50%) | -3.20M |
Net Income | -13.46M (+16.23%) | -11.58M (-22.59%) | -14.96M (+3.67%) | -14.43M (-4.12%) | -15.05M (-16.62%) | -18.05M (+23.63%) | -14.60M (+3.69%) | -14.08M (-1.61%) | -14.31M (-5.11%) | -15.08M (+19.68%) | -12.60M (+3.36%) | -12.19M (-10.37%) | -13.60M (+2.64%) | -13.25M (+3.19%) | -12.84M (+11.36%) | -11.53M (-10.62%) | -12.90M (+19.67%) | -10.78M (+26.38%) | -8.53M (+6.76%) | -7.99M (+28.25%) | -6.23M (+6.68%) | -5.84M (+32.73%) | -4.40M (+22.22%) | -3.60M (+12.50%) | -3.20M |
Comprehensive Income Net Of Tax | -13.78M (-75.37%) | -55.94M (+273.93%) | -14.96M (+3.67%) | -14.43M (-4.12%) | -15.05M (-75.34%) | -61.04M (+318.37%) | -14.59M (+3.62%) | -14.08M (-1.61%) | -14.31M (-73.22%) | -53.44M (+324.46%) | -12.59M (+3.28%) | -12.19M (-10.17%) | -13.57M (-73.12%) | -50.49M (+294.15%) | -12.81M (+11.01%) | -11.54M (-11.30%) | -13.01M (-61.26%) | -33.58M (+293.21%) | -8.54M (+6.88%) | -7.99M (+28.25%) | -6.23M (-63.44%) | -17.04M (+287.27%) | -4.40M | - | - |